NKT cell depletion in humans during early HIV infection (Q42221741)

18 October 2017

title

NKT cell depletion in humans during early HIV infection (English)

1 reference

18 October 2017

1 reference

18 October 2017

Dale I Godfrey

0 references

Caroline S Fernandez

1 reference

18 October 2017

Anthony D Kelleher

series ordinal

1 reference

18 October 2017

Robert Finlayson

series ordinal

1 reference

18 October 2017

publication date

29 April 2014

1 reference

Immunology & Cell Biology

18 October 2017

published in

1 reference

18 October 2017

1 reference

18 October 2017

1 reference

18 October 2017

page(s)

578-590

1 reference

NKT cells: what's in a name?

18 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FICB.2014.25

Going both ways: immune regulation via CD1d-dependent NKT cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2014.25

Raising the NKT cell family

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2014.25

Requirements for CD1d recognition by human invariant Valpha24+ CD4-CD8- T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2014.25

Lipid and glycolipid antigens of CD1d-restricted natural killer T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2014.25

Natural Killer T cell obsession with self-antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2014.25

21 January 2018

The biology of NKT cells

1 reference

https://api.crossref.org/works/10.1038%2FICB.2014.25

Innate and cytokine-driven signals, rather than microbial antigens, dominate in natural killer T cell activation during microbial infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2014.25

New ways to turn on NKT cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2014.25

Invariant natural killer T cells: an innate activation scheme linked to diverse effector functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2014.25

Clinical experience with α-galactosylceramide (KRN7000) in patients with advanced cancer and chronic hepatitis B/C infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2014.25

Harnessing invariant NKT cells in vaccination strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2014.25

Functionally distinct subsets of CD1d-restricted natural killer T cells revealed by CD1d tetramer staining

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2014.25

Distinct functional lineages of human V(alpha)24 natural killer T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2014.25

Ex-vivo analysis of human natural killer T cells demonstrates heterogeneity between tissues and within established CD4(+) and CD4(-) subsets.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2014.25

Selective loss of innate CD4(+) V alpha 24 natural killer T cells in human immunodeficiency virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2014.25

Natural killer T cells are targets for human immunodeficiency virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2014.25

CD1d-restricted human natural killer T cells are highly susceptible to human immunodeficiency virus 1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2014.25

Peripheral NKT cells in simian immunodeficiency virus-infected macaques

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2014.25

Identification and simian immunodeficiency virus infection of CD1d-restricted macaque natural killer T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2014.25

Loss of effector and anti-inflammatory natural killer T lymphocyte function in pathogenic simian immunodeficiency virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2014.25

Severe functional impairment and elevated PD-1 expression in CD1d-restricted NKT cells retained during chronic HIV-1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2014.25

Lower cytokine secretion ex vivo by natural killer T cells in HIV-infected individuals is associated with higher CD161 expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2014.25

Association of cells with natural killer (NK) and NKT immunophenotype with incident cancers in HIV-infected women

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2014.25

The immune response during acute HIV-1 infection: clues for vaccine development

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2014.25

Pathogenesis of HIV infection: what the virus spares is as important as what it destroys

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2014.25

Microbial translocation is a cause of systemic immune activation in chronic HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2014.25

Persistent immune activation in HIV-1 infection is associated with progression to AIDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2014.25

CD4 T cell depletion is linked directly to immune activation in the pathogenesis of HIV-1 and HIV-2 but only indirectly to the viral load.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2014.25

Relationship between T cell activation and CD4+ T cell count in HIV-seropositive individuals with undetectable plasma HIV RNA levels in the absence of therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2014.25

Shorter survival in advanced human immunodeficiency virus type 1 infection is more closely associated with T lymphocyte activation than with plasma virus burden or virus chemokine coreceptor usage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2014.25

Distinct homeostatic requirements of CD4+ and CD4- subsets of Valpha24-invariant natural killer T cells in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2014.25

Functional properties of a unique subset of cytotoxic CD3+ T lymphocytes that express Fc receptors for IgG (CD16/Leu-11 antigen).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2014.25

Plasma viral load and CD4+ lymphocytes as prognostic markers of HIV-1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2014.25

T cell activation in HIV-seropositive Ugandans: differential associations with viral load, CD4+ T cell depletion, and coinfection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2014.25

Preferential depletion of gut CD4-expressing iNKT cells contributes to systemic immune activation in HIV-1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2014.25

Inhibition of lipid antigen presentation in dendritic cells by HIV-1 Vpu interference with CD1d recycling from endosomal compartments

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2014.25

The response of natural killer T cells to glycolipid antigens is characterized by surface receptor down-modulation and expansion

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2014.25

Distinct and overlapping effector functions of expanded human CD4+, CD8α+ and CD4-CD8α- invariant natural killer T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2014.25

Valpha24-JalphaQ-independent, CD1d-restricted recognition of alpha-galactosylceramide by human CD4(+) and CD8alphabeta(+) T lymphocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2014.25

Delayed reconstitution of CD4+ iNKT cells after effective HIV type 1 therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2014.25

Mechanisms of HIV-associated lymphocyte apoptosis: 2010

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2014.25

Anti-apoptotic versus pro-apoptotic signal transduction: checkpoints and stop signs along the road to death

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2014.25

Induction of plasma (TRAIL), TNFR-2, Fas ligand, and plasma microparticles after human immunodeficiency virus type 1 (HIV-1) transmission: implications for HIV-1 vaccine design

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2014.25

Limited correlation between human thymus and blood NKT?cell content revealed by an ontogeny study of paired tissue samples

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2014.25

7 January 2021

Selective decrease in circulating V alpha 24+V beta 11+ NKT cells during HIV type 1 infection

1 reference

https://api.crossref.org/works/10.1038%2FICB.2014.25

7 January 2021

Cutting edge: Rapid recovery of NKT cells upon institution of highly active antiretroviral therapy for HIV-1 infection

1 reference

https://api.crossref.org/works/10.1038%2FICB.2014.25

7 January 2021

Function of NKT cells, potential anti-HIV effector cells, are improved by beginning HAART during acute HIV-1 infection

1 reference

https://api.crossref.org/works/10.1038%2FICB.2014.25

7 January 2021

Analysis of CD16+dim and CD16+bright lymphocytes--comparison of peripheral and clonal non-MHC-restricted T cells and NK cells

1 reference

https://api.crossref.org/works/10.1038%2FICB.2014.25

7 January 2021

Comparative gene expression analysis of NKT cell subpopulations

1 reference

https://api.crossref.org/works/10.1038%2FICB.2014.25

7 January 2021

Invariant NKT cells from HIV-1 or Mycobacterium tuberculosis-infected patients express an activated phenotype

1 reference

https://api.crossref.org/works/10.1038%2FICB.2014.25

7 January 2021

Glycolipid Antigen Drives Rapid Expansion and Sustained Cytokine Production by NK T Cells

1 reference

https://api.crossref.org/works/10.1038%2FICB.2014.25

7 January 2021

Conserved and Heterogeneous Lipid Antigen Specificities of CD1d-Restricted NKT Cell Receptors

1 reference

https://api.crossref.org/works/10.1038%2FICB.2014.25

7 January 2021

Ex-vivo α-Galactosylceramide activation of NKT cells in humans and macaques

1 reference

https://api.crossref.org/works/10.1038%2FICB.2014.25

7 January 2021

Identifiers

DOI

10.1038/ICB.2014.25

1 reference

Dimensions Publication ID

18 October 2017

1012808631

0 references

1 reference